ABVX:EPA
Abivax SA
၈၂.၁၀ €
arrow_upward
+၁.၄၈%(+၁.၂၀) 1D
အောက် ၆, GMT+၂ ၀၉:၀၅:၀၉ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ABVX...
Open
၈၁.၇၅ €
High
၈၂.၁၀ €
Low
၈၁.၅၅ €
Mkt. cap
၇၂၁.၂၀ ဋေ
Avg. vol.
၁.၅၇ သိန်း
Volume
၁.၅၉ ထောင်
52-wk high
၁၃၉.၀၀ €
52-wk low
၆၀.၄၅ €
EPS
-၅.၂၀ €
Shares outstanding
၈.၇၅ ကုဋေ
No. of employees
၉၈
Open
၈၁.၇၅ €
High
၈၂.၁၀ €
Low
၈၁.၅၅ €
Mkt. cap
၇၂၁.၂၀ ဋေ
Avg. vol.
၁.၅၇ သိန်း
Volume
၁.၅၉ ထောင်
52-wk high
၁၃၉.၀၀ €
52-wk low
၆၀.၄၅ €
EPS
-၅.၂၀ €
Shares outstanding
၈.၇၅ ကုဋေ
No. of employees
၉၈
News stories
From web sources and news partners
Simply Wall Street
·
ပြီးခဲ့သည့် ၃၀ မိနစ်
Microsoft (MSFT) Signs Long Term Xbox Deal And Expands AI Partner Ties
MarketBeat
·
ပြီးခဲ့သည့် ၇ မိနစ်
Community West Bancshares (NASDAQ:CWBC) Stock Has Consensus Price Target of $28.17
Yahoo Finance
·
ပြီးခဲ့သည့် ၃၉ မိနစ်
US Real Estate Stocks Hit All-Time Low Relative To S&P 500, Prompting Peter Schiff’s ‘Industry Is Dead’ Warning
Seeking Alpha
·
ပြီးခဲ့သည့် ၁ နာရီ
Cumberland's Monday Memo
Profile
Abivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.
Abivax has a program in clinical development with its lead drug candidate, obefazimod, to treat ulcerative colitis. Another program in Crohn’s disease is also in preparation and other potential inflammatory indications are being evaluated.
The company’s headquarters are based in Paris, France with a US office in Waltham, Massachusetts. Abivax’s Research and development work is conducted at its research center based in Montpellier, France. Wikipedia
About Abivax SA
CEOMarc de Garidel | Hartmut J. Ehrlich
Employees၉၈
Founded၂၀၁၃ ဒီ ၄
Headquarters-
Sector-
Websiteabivax.com